Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Janssen Presents Landmark Data From Invokana Study

Janssen’s Invokana became the only medicine in nearly 20 years and the first diabetes medicine ever to demonstrate a reduction in progression to end-stage renal failure in T2D patients with CKD.

Read More »

NASA’s Landmark Twins Study Reveals Resilience of Human Body in Space

Results from NASA’s landmark Twins Study reveals some interesting, surprising and reassuring data.

Read More »

Novo Nordisk, Gilead team up to test NASH treatment

Novo Nordisk and Gilead Sciences will join forces on a clinical trial combining drugs from the two pharmaceutical firms to treat a progressive fatty liver disease known as NASH.

Read More »

Potential Cancer “Vaccine” Shows Promise in Early-Stage NHL Trial

Researchers with the Icahn School of Medicine at Mount Sinai in New York have had promising results with a cancer vaccine.

Read More »

Caffeine could boost exercise performance

Taking caffeine before exercise could improve performance during a broad range of exercise tasks, according to a new review of past research.

Read More »

Eye Test May Offer Early Diagnosis for Alzheimer’s

A new report published by researchers at Northwestern University offers the possibility of an early diagnostic test for Alzheimer’s disease – via an eye test.

Read More »

Major study debunks healthy moderate drinking myth

Blood pressure and stroke risk rise steadily the more alcohol people drink, and previous claims that one or two drinks a day might protect against stroke are not true, according to a genetic study.

Read More »

NIH Begins Trial of Potential Universal Flu Vaccine

Scientists at the National Institutes of Health (NIH) launched a trial to examine a potential universal flu vaccine candidate, known as H1ssF_3928.

Read More »

ViiV Healthcare Announces 3-Year HIV Data for Juluca 2-Drug Combo

ViiV Healthcare presented three-year data from the SWORD 1 and 2 clinical trials in HIV.

Read More »

Exclusive: Astellas’ Xospata Provides Strong OS Benefits in Phase III Trial

Astellas Pharma’s blood cancer drug Xospata continues to show impressive results in the acute myeloid leukemia setting.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!

Subscribe

Ad Right Bottom